Skip to main content

Table 4 Toxicity of Dana Farber Consortium Protocol in the study population

From: Retrospective study of Dana Farber Consortium Protocol in newly diagnosed Egyptian adolescents and young adults with acute lymphoblastic leukemia: Tanta experience

Toxicity

Number

Percentage (%)

Neutropenia

41

100

Thrombocytopenia

29

70.73

Febrile neutropenia

28

68.29

Infection

27

65.85

Hyperglycemia

10

24.39

Mucositis

9

21.95

Venous thromboembolism

4

9.76

Neuropathy

4

9.76

Hepatoxicity

4

9.76

Pancreatitis

3

7.31

Avascular necrosis

3

7.31